EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Micro RNA 499 gene expression and interleukin 17 in Egyptian patients with Behçet’s disease

Dina F. Elessawi, Nashwa K. Radwan, Neveen M. Nosseir, Mohamed S. Tawfik

The Egyptian Rheumatologist · 2020-04 · 42 (2) · 135-139

DOI: 10.1016/j.ejr.2019.07.003 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Egyptian Rheumatologist, 2020-04. Verfasst von Dina F. Elessawi und 3 weiteren Autor:innen. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

High levels of interleukin 17 are expressed in active Behcet’s disease (BD) patients. High miRNA-499 relative expression is known to be associated with vascular manifestations and aneurysms in BD. To detect miRNA-499 relative expression and interleukin 17 serum levels in BD patients and find their association to clinical characteristics and disease activity. Blood samples were obtained from 40 Egyptian BD patients and 40 matched controls. The BD current activity form (BDCAF) was estimated. Relative expression of miRNA-499 was measured by real-time polymerase chain reaction. Serum IL-17 was also measured in by enzyme-linked immunosorbent assay. The mean age of the patients was 34.4 ± 10.9 years, disease duration was 8.9 ± 0.8 years and age at onset was 25.5 ± 7.2 years and they were 33 males and 7 females. All patients had oral ulcers, 85% had genital ulcers and 75% had ocular manifestations. The mean BDCAF was 1.54 ± 1.78. Levels of miRNA-499 relative expression were significantly higher in BD cases versus controls (4.2 ± 2.1 vs. 1.1 ± 0.3ΔΔCt respectively; p < 0.001). Levels of IL 17 were significantly higher in BD cases versus controls (86.9 ± 31.2 vs. 34.7 ± 4.4 pg/ml respectively; p < 0.001). There was a non-significant correlation between miRNA and IL 17 in patients (r = −0.06, p < 0.71). IL17 was significantly associated only with the occurrence of arthritis (p = 0.03). There was no significant association between miRNA-499 or IL-17 with the BDCAF (r = 0.22, p = 0.12 and r = −0.002, p = 0.99; respectively). Micro RNA-499 relative expression and IL17 levels were significantly higher in BD patients compared to the controls.

Zitieren

APA

Elessawi, D. F., Radwan, N. K., Nosseir, N. M., & Tawfik, M. S. (2020). Micro RNA 499 gene expression and interleukin 17 in Egyptian patients with Behçet’s disease. The Egyptian Rheumatologist, 42(2), 135-139. https://doi.org/10.1016/j.ejr.2019.07.003

Vancouver

Elessawi DF, Radwan NK, Nosseir NM, Tawfik MS. Micro RNA 499 gene expression and interleukin 17 in Egyptian patients with Behçet’s disease. The Egyptian Rheumatologist. 2020;42(2):135-139. doi:10.1016/j.ejr.2019.07.003

BibTeX
@article{Elessawi2020,
  author = {Elessawi, Dina F. and Radwan, Nashwa K. and Nosseir, Neveen M. and Tawfik, Mohamed S.},
  title = {Micro RNA 499 gene expression and interleukin 17 in Egyptian patients with Behçet’s disease},
  journal = {The Egyptian Rheumatologist},
  year = {2020},
  volume = {42},
  number = {2},
  pages = {135--139},
  doi = {10.1016/j.ejr.2019.07.003}
}
Kostenlos starten →